跳转至内容
Merck

Reducing the health consequences of opioid addiction in primary care.

The American journal of medicine (2013-05-15)
Sarah Bowman, Julie Eiserman, Leo Beletsky, Sharon Stancliff, R Douglas Bruce
摘要

Addiction to prescription opioids is prevalent in primary care settings. Increasing prescription opioid use is largely responsible for a parallel increase in overdose nationally. Many patients most at risk for addiction and overdose come into regular contact with primary care providers. Lack of routine addiction screening results in missed treatment opportunities in this setting. We reviewed the literature on screening and brief interventions for addictive disorders in primary care settings, focusing on opioid addiction. Screening and brief interventions can improve health outcomes for chronic illnesses including diabetes, hypertension, and asthma. Similarly, through the use of screening and brief interventions, patients with addiction can achieve improved health outcome. A spectrum of low-threshold care options can reduce the negative health consequences among individuals with opioid addiction. Screening in primary care coupled with short interventions, including motivational interviewing, syringe distribution, naloxone prescription for overdose prevention, and buprenorphine treatment are effective ways to manage addiction and its associated risks and improve health outcomes for individuals with opioid addiction.

材料
货号
品牌
产品描述

Sigma-Aldrich
纳洛酮盐酸盐二水合物 盐酸盐 二水合物, ≥98% (TLC and titration), powder
Supelco
纳洛酮 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®